Fasenra 30 mg solution for injection in pre-filled pen

Company:
AstraZeneca Pharmaceuticals (Ireland) DAC
Status:
Updated
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Benralizumab
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/17/1252/002

30 milligram(s)

R03DX10

Solution for infusion in pre- filled pen

EU/1/17/1252/001

30 milligram(s)

R03DX10

Solution for infusion in pre- filled syringe

Address:
College Business and Technology Park, Blanchardstown Road North, Dublin 15, D15 R925
Medical Information E-mail:
mipqc.ireland@astrazeneca.com
Telephone:
+353 1 609 7100
Fax:
+353 1 686 5038
Website:
https://contactazmedical.astrazeneca.com
Medical Information Direct Line:
1800 800 899

Address: